Unknown

Dataset Information

0

Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction.


ABSTRACT: Cardioprotection refers to a strategy aimed at enhancing survival pathways in the injured yet salvageable myocardium following ischemia-reperfusion. Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional receptor that can be targeted following reperfusion, to induce a cardioprotective signaling through the activation of the reperfusion injury salvage kinase (RISK) pathway. The data from preclinical studies with non-selective and selective LRP1 agonists are promising, showing a large therapeutic window for intervention to reduce infarct size after ischemia-reperfusion. A pilot clinical trial with plasma derived ?1-antitrypsin (AAT), a naturally occurring LRP1 agonist, supports the translational value of LRP1 as a novel therapeutic target for cardioprotection. A phase I study with a selective LRP1 agonist has been completed showing no toxicity. These findings may open the way to early phase clinical studies with pharmacologic LRP1 activation in patients with acute myocardial infarction (AMI).

SUBMITTER: Potere N 

PROVIDER: S-EPMC6387161 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction.

Potere Nicola N   Del Buono Marco Giuseppe MG   Niccoli Giampaolo G   Crea Filippo F   Toldo Stefano S   Abbate Antonio A  

International journal of molecular sciences 20190128 3


Cardioprotection refers to a strategy aimed at enhancing survival pathways in the injured yet salvageable myocardium following ischemia-reperfusion. Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional receptor that can be targeted following reperfusion, to induce a cardioprotective signaling through the activation of the reperfusion injury salvage kinase (RISK) pathway. The data from preclinical studies with non-selective and selective LRP1 agonists are promising, show  ...[more]

Similar Datasets

| S-EPMC6325593 | biostudies-literature
2022-12-12 | GSE185266 | GEO
| S-EPMC4599491 | biostudies-literature
| S-EPMC8623357 | biostudies-literature
2022-12-12 | GSE183932 | GEO
| S-EPMC4069269 | biostudies-other
2022-12-12 | GSE185265 | GEO
| S-EPMC5981007 | biostudies-literature
| S-EPMC8103174 | biostudies-literature
2018-12-08 | GSE123487 | GEO